Granted Patent
Utility
US 5,750,132 · App. 08/451,370
Treatment of adverse effects associated with administration of extracellular hemoglobin
Inventor:
Michael J. Gerber
Patented Case
View Patent ↗
Granted: May 12, 1998
Filed: May 26, 1995
Inventor
Michael J. Gerber
Assignee (at issue)
Somatogen, Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.